Brookdale Senior Living Inc.
NYSE:BKDMedical - Care Facilities
+$0.05 today
- Market cap
- $2.06B
- Beta
- 0.62
- P/E (TTM)
- -15.9
- EPS (TTM)
- -$0.86
Volume 4.89M
Average 3.63M
BKD Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Brookdale Senior Living Inc.NYSE: BKD
Revenue · Q3 FY2026 · quarter ended Sep 2026
Revenue declines year over year
Q3 FY2026 revenue of $712.07M fell 8.5% year over year, behind the -5.4% change in trailing-twelve-month revenue. Sequentially, it fell 0.9% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 3 analysts of $2.9B (-7.1%) for the fiscal year ending Dec 2026, a slowdown from the +4.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $712.07M-0.9% QoQ
- Last fiscal yearDec 2025
- $3.12B+4.8% YoY
- LTMSep 2026
- $2.95B-5.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -8.5% | -6.5% | +2.0 pp |
| 1 year | +4.8% | -7.1% | -11.9 pp |
| 3-year CAGR | +4.4% | -0.1% | -4.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 3.12B USD
- Year-over-year change
- +4.8%
- 4-year CAGR
- +3.3%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.12B | +4.8% |
| FY2024 | 2024-12-31 | 2.98B | +4.0% |
| FY2023 | 2023-12-31 | 2.87B | +4.5% |
| FY2022 | 2022-12-31 | 2.74B | -0.0% |
| FY2021 | 2021-12-31 | 2.75B | — |
Revenue vs competitors
How BKD compares with its peers on the latest reported figures
- BKD's LTM Sep 2026 revenue of $2.95B is the 3rd highest of the 10 companies compared; the peer median is $1.48B.
- Its year-over-year change of -5.4% is the 7th highest of 8, against a peer median of +6.7%.
- Over three fiscal years its annual growth of +4.4% compares with a peer median of +12.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $6.43B | +6.7% | +7.2% |
| LTM Sep 2026 | $3.41B | +4.5% | +8.3% | |
| LTM Sep 2026 | $2.95B | -5.4% | +4.4% | |
| LTM Oct 2026 | $2.68B | +16.8% | +10.8% | |
| LTM Sep 2026 | $1.58B | +5.6% | +12.2% | |
| LTM Jun 2026 | $1.48B | +15.9% | +14.4% | |
| LTM Sep 2026 | $182.57M | +121.2% | +678.6% | |
| LTM Jun 2026 | $117M | -55.3% | +30.2% | |
| LTM Jun 2026 | $3.6M | — | — | |
| LTM Jun 2026 | $0 | — | — | |
| Peer median (excluding BKD) | $1.48B | +6.7% | +12.2% | |
Competitors are the stored peer set for BKD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.75B | 2.74B | 2.87B | 2.98B | 3.12B |
| Cost of Revenue | 2.26B | 2.23B | 2.12B | 2.18B | 2.48B |
| Gross Profit | 488.58M | 513.94M | 744.71M | 807.43M | 645.02M |
| Gross Margin | 17.8% | 18.7% | 26.0% | 27.1% | 20.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 359.27M | 333.89M | 384.52M | 386.63M | 349.89M |
| Operating Expenses | 705.52M | 556.63M | 726.3M | 760.9M | 627.86M |
| Depreciation & Amortization | 345.06M | 353.89M | 350.41M | 367.51M | 370.3M |
| EBITDA | 425.23M | 319.92M | 376.99M | 430.53M | 358.72M |
| EBITDA Margin | 15.5% | 11.7% | 13.1% | 14.4% | 11.5% |
| Operating Income | (216.94M) | (42.69M) | 18.41M | 46.53M | 17.17M |
| Operating Margin | -7.9% | -1.6% | 0.6% | 1.6% | 0.5% |
| Interest Income | 1.35M | 6.94M | 23.15M | 19.16M | 12.38M |
| Interest Expense | 187.69M | 205.93M | 231.72M | 243.29M | 253.11M |
| Other Income / Expenses | 109.41M | (197.21M) | (198.7M) | (243.88M) | (281.86M) |
| Income Before Tax | (107.53M) | (239.9M) | (180.29M) | (197.35M) | (264.7M) |
| Pre-Tax Margin | -3.9% | -8.7% | -6.3% | -6.6% | -8.5% |
| Income Tax Expense | (8.16M) | (1.56M) | 8.78M | 4.65M | (1.95M) |
| Net Income | (99.29M) | (238.43M) | (189.01M) | (201.94M) | (262.69M) |
| Net Margin | -3.6% | -8.7% | -6.6% | -6.8% | -8.4% |
| EPS (Basic) | (0.54) | (1.25) | (0.84) | (0.89) | (1.11) |
| EPS (Diluted) | (0.54) | (1.25) | (0.84) | (0.89) | (1.11) |
| Weighted Avg Shares | 184.98M | 190.46M | 225.21M | 227.53M | 234.33M |
| Weighted Avg Shares (Diluted) | 184.98M | 190.46M | 225.21M | 227.53M | 234.33M |
Brookdale Senior Living Inc.
NYSE:BKD
Intrinsic Alpha fair value
Locked
Current Price
$8.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.